Letters to the Editor

PTPN11 mutations define a rare but highly adverse subset of myelodysplastic syndromes

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Haematologica Early view Jul 3, 2025 https://doi.org/10.3324/haematol.2025.287874